longbridgelongbridge
  • Products
  • Fees
  • Download
  • Promotions
    Welcome RewardsReferral ProgramUS Pre-Market Options Trading
  • For Institutions
    Corporate ServicesDevelopers
  • Help
  • About
    About LongbridgeLicense & RegulatoryMedia CoverageJoin Us
longbridge
  • Home
  • Discover
    Discover
    Global MarketsStock ScreenerFinancial Calendar
  • News & Info
    News & Info
    NewsInsightsLiveAcademy
  • Watchlist
  • Trade
  • Notification
  • LongbridgeAI
Home
Discover
News & Info
Watchlist
Trade
LongbridgeAI
Quote ListQuote List

vTv Therap(VTVT.US)

Last Updated 19:00:00 ET
longbridge loading
News
Financials
Overview

vTv Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.

benzinga_article·05/15/2026 00:35
US
VTVT
+2.82%
US
PBE
+0.11%
US
IBB
+0.10%
benzinga_article·05/15/2026 00:35
US
VTVT
+2.82%
US
PBE
+0.11%
US
IBB
+0.10%

Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing

PR Newswire·05/13/2026 22:48
US
VTVT
+2.82%
US
TVTX
-1.47%
US
RTSL
0.00%
PR Newswire·05/13/2026 22:48
US
VTVT
+2.82%
US
TVTX
-1.47%
US
RTSL
0.00%

vTv Therapeutics (VTVT) Projected to Post Earnings on Wednesday

Market Beat·05/11/2026 18:49
US
VTVT
+2.82%
Market Beat·05/11/2026 18:49
US
VTVT
+2.82%

09:26 ETVector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery

prnewswire·05/01/2026 21:28
US
VTVT
+2.82%
US
PBE
+0.11%
US
XBI
-0.69%
prnewswire·05/01/2026 21:28
US
VTVT
+2.82%
US
PBE
+0.11%
US
XBI
-0.69%
© 2026 Longbridge|Disclaimer

Event Tracking

May14
vTv Therapeutics released FY2026 Q1 earnings on May 13 (EST), actual revenue USD 36.84 M (forecast USD 10 M), actual EPS USD 1.65 (forecast USD 0.442)
03:00
Mar11
vTv Therapeutics released FY2025 Q4 earnings on March 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5732 (forecast USD -1.08)
03:00
vTv Therapeutics released FY2025 earnings on March 10 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -3.2021 (forecast USD -4.21)
03:00
Nov7
vTv Therapeutics released FY2025 9 Months earnings on November 6, 2025 (EST), actual revenue USD 0, actual EPS USD -2.771
04:00
vTv Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.0797 (forecast USD -0.97)
04:00
Aug13
vTv Therapeutics released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.9199 (forecast USD -0.85)
03:00

Schedules & Filings

Schedules
Filings
May13
Earning Release(EST)

FY2026 Q1 Earning Release (USD) Revenue 36.84 M, Net Income 24.13 M, EPS 1.65

Mar10
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Net Income -7.138 M, EPS -0.5752

Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.698 M, EPS -1.0797

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
INM
1.600
+135.05%
+0.919
AMPGZ
0.5800
+132.00%
+0.330
AMST
1.730
+120.07%
+0.944
CNEY
1.610
+119.77%
+0.877
AMPGR
0.5000
+102.02%
+0.253
NXXT
0.8201
+100.02%
+0.410
WNW
4.750
+97.10%
+2.340
GIPR
0.4290
+75.89%
+0.185
MTVA
1.880
+69.37%
+0.770
SVRN
8.200
+49.64%
+2.720
View More